Sentiment Trading

Longeveron Inc. has appointed Than Powell as Chief Business Officer and announced significant progress in its clinical trials, including completion of enrollment in a pivotal Phase 2b trial for its HLHS treatment.

Longeveron Inc. is a clinical-stage biotech company pioneering cellular therapies to address aging-related and life-threatening conditions, with a promising future despite recent market fluctuations.